In this study, we delineated the potential role of the calcitonin–AMYR axis in depression by exploiting both the agonist (e.g., sCT) and the inhibitor/antagonist of AMYR (e.g., AC187) (Hay et al., 2005). Here, CALCA is linked to depressive symptom measurement.